Study Details
Testing Antifungal Treatment for Children and Adolescents with Uncomplicated Candidemia
(IRB#: IRB_00174179)
Candidemia is an infection in the blood that can cause hospitalization. An antifungal treatment is done to help the condition. This study will test whether a 7-day antifungal treatment is more effective for adults and children compared to a standard 14-day course, with a lower risk of negative drug-related events. People in the study will be randomly chosen to be treated with the 7-day anti-fungal treatment or the 14-day course. Being in the study requires in-person visits at the study clinic and lasts about 21 days. Medical tests will be done to track the health of participants.
- All genders
- Under 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Under 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages up to 18 years old
- Diagnosed with uncomplicated candidemia
- Receiving or received echinocandin (a drug used to treat candidemia)
- Known improvement of candidemia
- Able to attend in person at the study clinic
Exclusion Criteria
- Currently or anticipated to be neutropenic (not enough white blood cells in the blood)
- Receiving the treatment for another health condition
- Previous enrollment in the study
- Pregnancy of childbearing age
Will I be paid for my time?
Yes
IRB#: IRB_00174179
PI: Sonia Mehra
Department: PEDIATRIC INFECTIOUS DISEASES
Approval Date: 2024-08-13 22:58:00
Specialties: Infectious Diseases